A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
BioNTech SE
BioNTech SE
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
OncoC4, Inc.
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)